Overview
Melinda Lillesand practices practicing medicine in Stavanger, Norway.
Her clinical expertise encompasses Bladder Cancer, PIK3CA-Related Overgrowth Spectrum, and Urothelial Cancer.
She is actively involved in clinical research, co-authoring 10 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Melinda Lillesand
Is Melinda Lillesand a top-rated expert for Bladder Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Melinda Lillesand is classified as an Experienced expert for Bladder Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Melinda Lillesand participate in research or clinical trials?
Yes. Melinda Lillesand has published 10 articles and abstracts on conditions like Bladder Cancer. You can view a list of Melinda Lillesand's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Bladder CancerMs. Lillesand isExperienced. Learn about Bladder Cancer.
- PIK3CA-Related Overgrowth SpectrumMs. Lillesand isExperienced. Learn about PIK3CA-Related Overgrowth Spectrum.
- Urothelial CancerMs. Lillesand isExperienced. Learn about Urothelial Cancer.